127 related articles for article (PubMed ID: 12613668)
41. Raptor is phosphorylated by cdc2 during mitosis.
Gwinn DM; Asara JM; Shaw RJ
PLoS One; 2010 Feb; 5(2):e9197. PubMed ID: 20169205
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner.
Niiya F; Xie X; Lee KS; Inoue H; Miki T
J Biol Chem; 2005 Oct; 280(43):36502-9. PubMed ID: 16118207
[TBL] [Abstract][Full Text] [Related]
43. Phosphorylation of caldesmon by p21-activated kinase. Implications for the Ca(2+) sensitivity of smooth muscle contraction.
Foster DB; Shen LH; Kelly J; Thibault P; Van Eyk JE; Mak AS
J Biol Chem; 2000 Jan; 275(3):1959-65. PubMed ID: 10636898
[TBL] [Abstract][Full Text] [Related]
44. Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.
Wang Z; Jiang H; Yang ZQ; Chacko S
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11899-904. PubMed ID: 9342334
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers.
Leung WK; Ching AK; Wong N
Mol Cell Biochem; 2011 Apr; 350(1-2):201-6. PubMed ID: 21184254
[TBL] [Abstract][Full Text] [Related]
46. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.
Neef R; Gruneberg U; Kopajtich R; Li X; Nigg EA; Sillje H; Barr FA
Nat Cell Biol; 2007 Apr; 9(4):436-44. PubMed ID: 17351640
[TBL] [Abstract][Full Text] [Related]
47. Genetic interactions between Hsp90 and the Cdc2 mitotic machinery in the fission yeast Schizosaccharomyces pombe.
Muñoz MJ; Jimenez J
Mol Gen Genet; 1999 Mar; 261(2):242-50. PubMed ID: 10102358
[TBL] [Abstract][Full Text] [Related]
48. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.
Qiao M; Shapiro P; Fosbrink M; Rus H; Kumar R; Passaniti A
J Biol Chem; 2006 Mar; 281(11):7118-28. PubMed ID: 16407259
[TBL] [Abstract][Full Text] [Related]
49. The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control.
Marklund U; Osterman O; Melander H; Bergh A; Gullberg M
J Biol Chem; 1994 Dec; 269(48):30626-35. PubMed ID: 7982983
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the functional domains on the C-terminal region of caldesmon using full-length and mutant caldesmon molecules.
Wang Z; Horiuchi KY; Chacko S
J Biol Chem; 1996 Jan; 271(4):2234-42. PubMed ID: 8567684
[TBL] [Abstract][Full Text] [Related]
51. Actomyosin cross-linking by caldesmon in non-muscle cells.
Goncharova EA; Shirinsky VP; Shevelev AY; Marston SB; Vorotnikov AV
FEBS Lett; 2001 May; 497(2-3):113-7. PubMed ID: 11377424
[TBL] [Abstract][Full Text] [Related]
52. Caldesmon regulates actin dynamics to influence cranial neural crest migration in Xenopus.
Nie S; Kee Y; Bronner-Fraser M
Mol Biol Cell; 2011 Sep; 22(18):3355-65. PubMed ID: 21795398
[TBL] [Abstract][Full Text] [Related]
53. Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.
Dierks S; von Hardenberg S; Schmidt T; Bremmer F; Burfeind P; Kaulfuß S
Oncotarget; 2015 May; 6(15):13591-606. PubMed ID: 26079947
[TBL] [Abstract][Full Text] [Related]
54. The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression.
Wells NJ; Watanabe N; Tokusumi T; Jiang W; Verdecia MA; Hunter T
J Cell Sci; 1999 Oct; 112 ( Pt 19)():3361-71. PubMed ID: 10504341
[TBL] [Abstract][Full Text] [Related]
55. cGMP-dependent protein kinase Iβ regulates breast cancer cell migration and invasion via interaction with the actin/myosin-associated protein caldesmon.
Schwappacher R; Rangaswami H; Su-Yuo J; Hassad A; Spitler R; Casteel DE
J Cell Sci; 2013 Apr; 126(Pt 7):1626-36. PubMed ID: 23418348
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of smooth muscle actomyosin ATPase by caldesmon is associated with caldesmon-induced conformational changes in tropomyosin bound to actin.
Horiuchi KY; Wang Z; Chacko S
Biochemistry; 1995 Dec; 34(51):16815-20. PubMed ID: 8527457
[TBL] [Abstract][Full Text] [Related]
57. Nucleolin, defective for MPF phosphorylation, localizes normally during mitosis and nucleologenesis.
Zhu Y; Lu D; DiMario P
Histochem Cell Biol; 1999 Jun; 111(6):477-87. PubMed ID: 10429970
[TBL] [Abstract][Full Text] [Related]
58. Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation.
Gusev NB
Biochemistry (Mosc); 2001 Oct; 66(10):1112-21. PubMed ID: 11736632
[TBL] [Abstract][Full Text] [Related]
59. Mutagenesis analysis of functionally important domains within the C-terminal end of smooth muscle caldesmon.
Wang Z; Chacko S
J Biol Chem; 1996 Oct; 271(41):25707-14. PubMed ID: 8810349
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the carboxyl-terminal 10-kDa cyanogen bromide fragment of caldesmon as an actin-calmodulin-binding region.
Bartegi A; Fattoum A; Derancourt J; Kassab R
J Biol Chem; 1990 Sep; 265(25):15231-8. PubMed ID: 2394719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
